PTH Drug Passes Test in Dialysis Patients
(MedPage Today) -- An investigational drug for secondary hyperparathyroidism in chronic kidney disease patients on dialysis met its primary endpoint, Amgen announced.
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Chronic Kidney Disease | Dialysis | Hyperparathyroidism | Primary Care | Urology & Nephrology